Back to Japan Life Sciences: 4HourPass

Finglobedirect offers Rankings 25 for key financial variables that enable investors, analysts, regulators, and market competitors to identify Life Science companies that are highly ranked among leading companies in Japan. We perform the data analysis quickly, efficiently and transparently so that the clients can benefit from regularly updated rankings without the need to analyze - or pay for - the clients' own data sources. The ranking reports include rankings, geographic and product segment analysis, indicators, and diversification index.

Rankings measure the relative performance and condition of various group of companies. We apply analytical factors covering the key dimensions of efficiency, growth, and profitability, ranking the companies from strongest to weakest, both overall, and within each dimension. Our rankings show how the Japanese Life Sciences companies are performing relative to each other in their shared economic environment.

Finglobedirect provides key variable values, derived by the Japanese Life Science companies from various geographic and product segments.

Finglobedirect Indicators provide quick overview of the Japanese Life Science companies q-o-q growth. Finglobedirect Indicators compute rolling average growth (of last 3 quarters) for Total Sales / Net Income and Operating Cash Flow, assign weighted scale in the range of -5 to 5 for each of computed rolling average values based on positive / negative growth of a given company, and compute sum of weighted scales for each variable and assign Finglobedirect Indicators to each company based on weighted scale values.

Diversification Index provides Product / Geographic segment exposure details. Diversification Index computes % exposure for each of segment within segment category, assign 33 diversification index points if % exposure for a given segment within segment category is greater than 33%, else assign exact % exposure values as diversification index points.